(Q78061392)

English

Phase II trial of 9-aminocamptothecin (NSC 603071) administered as a 120-hr continuous infusion weekly for three weeks in metastatic colorectal carcinoma

scientific article published on 01 January 1998

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10426669%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Phase II trial of 9-aminocamptothecin (NSC 603071) administered as a 120-hr continuous infusion weekly for three weeks in metastatic colorectal carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10426669%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

phase II clinical trial

1 reference

based on heuristic

inferred from title

metastatic colorectal carcinoma

1 reference

based on heuristic

inferred from title

author name string

R Pazdur

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10426669%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

D C Medgyesy

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10426669%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

R J Winn

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10426669%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

S R Dakhil

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10426669%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

D F Moore

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10426669%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

A Scalzo

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10426669%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

P M Hoff

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10426669%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

S G Arbuck

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10426669%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

J L Abbruzzese

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10426669%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

publication date

1 January 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10426669%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10426669%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10426669%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10426669%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

341-346

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10426669%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Phase I and pharmacologic study of 9-aminocamptothecin given by 72-hour infusion in adult cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/10426669

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comprehensive criteria for assessing therapy-induced toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/10426669

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/10426669

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary pharmacologic and clinical evaluation of camptothecin sodium (NSC-100880).

1 reference

https://pubmed.ncbi.nlm.nih.gov/10426669

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Irinotecan is an active agent in untreated patients with metastatic colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10426669

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of 9-aminocamptothecin administered as a 72-hour continuous infusion in metastatic colorectal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10426669

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA topoisomerase I--targeted chemotherapy of human colon cancer in xenografts

1 reference

https://pubmed.ncbi.nlm.nih.gov/10426669

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The current status of camptothecin analogues as antitumor agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/10426669

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues

1 reference

https://pubmed.ncbi.nlm.nih.gov/10426669

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10426669

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. CPT-11 Gastrointestinal Cancer Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10426669

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA topoisomerases as anticancer drug targets

1 reference

https://pubmed.ncbi.nlm.nih.gov/10426669

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies on the antitumor activity, mechanism of action, and cell cycle effects of camptothecin

1 reference

https://pubmed.ncbi.nlm.nih.gov/10426669

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of malignant melanoma with camptothecin (NSC-100880)

1 reference

https://pubmed.ncbi.nlm.nih.gov/10426669

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I and pharmacokinetic study of a new camptothecin derivative, 9-aminocamptothecin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10426669

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The determinatio of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent

1 reference

https://pubmed.ncbi.nlm.nih.gov/10426669

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10426669

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of the active lactone form of 9-aminocamptothecin in plasma using solid-phase extraction and high-performance liquid chromatography

1 reference

https://pubmed.ncbi.nlm.nih.gov/10426669

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

9-Aminocamptothecin and beyond. Preclinical and clinical studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/10426669

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q78061392&oldid=2224684346"